Gregory T. Went, Chief Executive Officer, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 10,583 shares at $18.00 ($191K) on 2015-04-21, disclosed to the SEC on 2015-04-22.
Scheduled sale ($191k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 2,610 | $47K | 24.7% |
| 2 | $18.00 | 5,200 | $94K | 49.1% |
| 3 | $18.00 | 1,811 | $33K | 17.1% |
| 4 | $18.01 | 962 | $17K | 9.1% |
| Total | $18.00 avg | 10,583 | $191K | 100% |
| Filing → |
| ADMS | SELL | 2018-03-22 | $234K | — | Filing → |
| ADMS | SELL | 2017-03-22 | $48K | — | Filing → |
| ADMS | SELL | 2015-05-14 | $49K | — | Filing → |